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Volume 49, Number 5S Rapid Paced Paper Sessions 47Smicroemboli was significantly higher in CAS group than CEA group (46.3%
and 12% respectively, P0.05) despite a relative low incidence of associated
neurologic symptoms (2.6 % vs. 2%). Thirty patients (16 CAS and 14 CEA)
with 50 DWI lesions (mean size 46.57mm2, ranging 16 to 128mm2) were
further analyzed. During a mean MRI follow-up of 10 months (range, 2 to
23months), residual MRI abnormalities were only identified in DWI lesions
larger than 60mm2 (n5, P0.001). CEA group had fewer but larger
ipsilaterally distributed emboli (total 12 lesions, mean 79mm2) comparing
to CAS group (total 38 lesions, mean 27.5mm2, P0.05). Regression
analyses of 68 CAS patients (mean age 71 years, range, 53-91 years) showed
that date of procedure prior to 1/2007, coronary artery disease, diabetes,
and perioperative troponin elevation were significant predictors of micro-
emboli (P0.03). Date of procedure was the only predictor of bilateral
hemispheres microemboli (p0.025).
Conclusions: Carotid interventions are associated with significant
DWI lesions despite absence of clinical symptoms. Risks of microemboli
correlate to physician experience and patient selection. Larger DWI lesions
(60mm2) can lead to long-term residual structure abnormalities that
warrants further neurocognitive evaluation.
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Objectives: Ischemic steal (IS) associated with an AV access is rare, but
can result in severe complications. Multiple techniques have been described
to treat IS with varying degrees of success. This study compares these
options.
Methods: Patients with IS from June 2003 to August 2008 were
reviewed. Demographics, type of AV access, management technique and
success of intervention were recorded. Success was defined as resolution of
IS symptoms while preserving access function. Further, 100 consecutive AV
access procedures were reviewed for current practice patterns. We analyzed
data using z- and chi-squared tests. The study was approved by our IRB.
Results: A total of 114 patients with IS had a mean age of 65 years
(range 20-90) and were predominantly female (66%), diabetic (61%), and
had proximal brachio-cephalic or brachio-basilic fistulas (69%). Women
were noted to have a brachial artery origin more frequently than men (OR
3.1, p0.009) in current practice. Forty-four mild cases were observed
uneventfully. Results of 87 interventions on 70 patients are in Table I. Of
these, 31 early procedures (30 days from index fistula) weremostly ligation
(42%) or banding (45%) while Distal Revascularization, Interval Ligation
(DRIL) was the most frequent choice for late interventions (38%). DRIL
had a better success rate than banding (p  0.05). Of the 11 patients
requiring repeat intervention, the majority had failed banding procedures
(73%). In our current practice, 18% of patients had an AV fistula with the
proximal radial artery (PRA) as the inflow source, while this type of fistula
accounted for only 2% of all IS patients. Ligation resolved symptoms in all
patients, but the AV access was lost.
Conclusions: Among various options to treat IS, banding has a low
success rate and high likelihood for re-intervention, while DRIL is particu-
larly effective, though not uniformly. Women have more IS probably be-
cause they frequently have more proximal access. Use of the PRA as the
inflow source may decrease the incidence of IS.
Success of management techniques
Management technique N Follow-up Success (95% CI)
Ligation 27 25 0% (NA)
Banding 22 21 38% (17% - 59%)
DRIL 21 20 80% (62% - 98%)*
Improve inflow 9 7 43% (NA)
Revision using distal
inflow (RUDI)
4 3 100% (NA)
Proximalization of arterial
inflow (PAI)
3 3 100% (NA)
Distal revascularization 1 1 100% (NA)*Statistically significant at p0.05.Author Disclosures: N. Gupta, None; T.H. Yuo, None; G. Konig,
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Objective: To estimate the size of the future workforce in Vascular
Surgery (VS) and the added cost associated with addressing the projected
shortage in the United States.
Methods: The net supply (number of VS currently practicing, new
graduates entering the workforce and those retiring) for each decade was
calculated. The projected population for each decade was determined by US
Census Bureau figures. Some of the assumptions included: (1) In 2008 the
population was 300,000,000; 2) There were 2783 board certified VS in
2008; (3) VS will practice 30 years from board certification to retirement;
(4) there will be 105 board certifications and 93 retirements a year; (5)
Vascular operations will remain at 284 per 100,000 population and (6)
Salaries of trainees will be $50,000 with benefits of 30%, and $ 15,000 of
additional DME costs.
Results:
Population Analysis:
Year
Projected
population
Vascular
surgeons
needed
Vascular
surgeons
in practice Shortage % Shortage
2000 282,000,000
2010 309,000,000 2,866 2,807 59 2.1%
2020 336,000,000 3,117 2,927 190 6.1%
2030 364,000,000 3,377 3,047 330 9.8%
2040 392,000,000 3,636 3,150 486 13.4%
2050 420,000,000 3,896 3,150 746 19.2%
Workload Analysis
Year
Projected
population
Estimated
work load for
population
Vascular
surgeons
needed
Vascular
surgeons
in practice Shortage
Percent
shortage
2000 282,000,000
2010 309,000,000 877,560 4,112 2,807 1,305 31.7%
2020 336,000,000 954,240 4,472 2,927 1,545 34.5%
2030 364,000,000 1,033,760 4,844 3,047 1,797 37.1%
2040 392,000,000 1,113,280 5,217 3,150 2,067 39.6%
2050 420,000,000 1,192,800 5,590 3,150 2,440 43.6%
Conclusions: A conservative estimate by both population and work-
load analysis, disregarding ageing of the population, lifestyle choices of
future VS and increasing demand for services, indicates a shortage of VS in
the future. The cost of training enough VS surgeons by 2030 will be
between $1,166,400,000 and $2,182,320,000.Unless the Balanced Budget
Act of 1997 is revised by Congress, the cost to train the additional VS
remains a significant barrier.
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derin1, Lorena DeMarco-Garcia1, Nicole Johnson2, Richard Schultzer1,
Mihai Rosca1,Mark Kissin1, John Chang1, Omid Rahmani1, Toufic K Safa1,
William Purtill1, Mark Gennarro1, Kambhampaty Krishnasastry1. 1North
Shore-LIJ Healthcare System, Lake success, NY; 2Albert Einstein College of
Medicine, Bronx, NYObjective: To evaluate the utility of aneurysm sac pressure and aneu-
rysm volume monitoring for EVAR surveillance.
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doSure® implantation during Jan. 2007-Dec. 2008. Post-operative intrasac
pressure was measured at every office visit. Ratios of sac to systemic pressures
were recorded as mean (MPI) and pulse (PPI) pressure indexes. CT scans
were obtained at every 6 months or anytime an endoleak was suspected.
Aneurysm sac volume was quantitated after constructed by volume render-
ing of CTA.
Results: Technical success of EndoSure implantation was 98%
(175/178). No sensor malfunctioned after successful implantation.
Mean follow-up was 12.5 months (range 1 - 24 months). In EVAR
without endoleak (143/175), sac pressure decreased progressively and
remained plateaued (MPI  0.5, PPI  0.5) for 24 months. There was a
strong correlation (r  0.87) between diminishing sac pressure and
shrinking sac size. Thirty-two endoleaks developed (18.5%). Five type I
endoleaks (3%) were discovered by sac pressure elevation (MPI  0.5)
and pulsatile waveform (PPI  0.5) (Positive Predictive Value 100%).
Twenty-seven type II endoleaks or endotensions (15.5%) were suspected
with variant MPI elevation ( 0.5) but normal PPI ( 0.5)(PPV 100%).
Endoleaks with markedly elevated sac pressure (MPI  1.0) were fol-
lowed by sac volume expansion.
Conclusions: EVAR can be surveillanced safely by sac pressure
monitoring up to 2 years. The type of endoleak can be predicted based on
the character of sac pressure elevation. Suspected endoleak should be
further examined by CTA with sac volume quantitation. Consistent sac
pressure elevation with sac volume expansion warrants aggressive
intervention.
Summary of sac pressure and volume change during
EVAR surveillance
N  175 MPI PPI Sac volume
No endoleak 143  0.5  0.5 Decrease
Type I endoleak 5  0.5  0.5 Same or
increase
Type II endoleak 25  0.5  0.5 Increase if MPI
 1.0
Endotension 2  0.5  0.5 Increase if MPI
 1.0
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Background: The mortality of ruptured abdominal aortic aneurysm
(rAAA) repair is currently 40-50%. Reports indicate that endovascular repair
(EVAR) is feasible for rAAA and may offer potential benefits over open
repair. We examined the NSQIP database to compare 30-day multicentre
outcomes for EVAR vs. open rAAA repair.
Methods: Patients that underwent rAAA repair in the NSQIP database
from 2005 to 2007 were identified through a combination of CPT codes
and ICD-9 diagnoses. Preoperative comorbidities, operative duration and
transfusion, and 30 day outcomes were evaluated using T-tests.
Results: 76.8% of patients underwent open repair as shown:
EVAR Open repair
All
rAAA
Year n % n % n
2005 4 9.3 39 90.7 43
2006 32 24.2 100 75.8 132
2007 63 25.0 189 75.0 252
Total 99 23.2 326 76.8 427EVAR Open repair P
Patient
Characteristics
Age mean years 
S.D.
72.110.5 73.69.3 0.167
Male % 79.8 76.5 0.497
Smoking % 39.4 30.8 0.111
COPD % 19.2 13.4 0.156
Hx. of Angina, MI
or CHF %
9.1 5.8 0.246
Prior Cardiac
Operation or
PCI %
27.3 21.3 0.218
Treated
Hypertension %
64.6 66.8 0.696
Preop. Transfusion
4 u PRBCs %
2.0 6.1 0.108
Preop Albumin
mean g/dL 
S.D.
3.560.78 3.300.73 0.017*
Intraoperative
Variables
Operative time
mean min. 
S.D.
195.0113.4 203.389.5 0.449
Units PRBC
Intraop. mean 
S.D.
4.26.0 11.88.9 0.001*
Postoperative
Outcomes
30 day composite
morbidity (%)
45.5 62.5 0.003*
30 day mortality
(%)
22.2 37.2 0.003*
Wound dehiscence
(%)
0 4.6 0.030*
Ventilator  48
hours (%)
23.2 47.6 0.001*
Sepsis/septic
shock (%)
19.2 29.9 0.037*
Pulmonary adverse
events (%)
34.3 50.0 0.006*
Patient characteristics, intraoperative variables and postoperative outcomes
are summarized in the table above. Groups were comparable in terms of
comorbid conditions, age and gender; requirement for preoperative blood
transfusion indicative of hemodynamic status was similar. Open repair
resulted in much higher requirement for blood transfusion(P0.001) with-
out difference in operating time. Mortality was higher after OR (
P0.003).There was no difference in the rate of cardiac, neurologic or renal
complications but composite morbidity was higher after open repair second-
ary to wound, septic and pulmonary complications.
Conclusions: EVAR appears to offer superior 30 day outcomes after
repair of rAAA. We did not access aneurysm anatomic characteristics to deter-
mine how many patients that had open repair would have been candidates for
EVAR.Theanatomic suitability forEVARhasbeen reported at60% for rAAA.Less
that ¼ of the NSQIP database patients underwent EVAR; preoperative albumin
which is a strong predictor of morbidity and mortality was significantly lower in
patients undergoingopen repair. There has beenno increase in the ratio ofEVAR/
open repair in the last two years. EVAR for rAAA with favorable anatomy could
potentially result in lower mortality andmorbidity as compared to open repair.
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